Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Mimicking fetal wound environments may enable scarless healing in adults.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

S100A6 protein is linked to disease progression, especially in cancers.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Targeting the Smoothened receptor shows promise for treating certain cancers.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

WNT10B affects hair growth by altering gene activity in hair cells.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

Curcumin applied to the skin can start hair growth in mice.

Some maize lines resist stalk rot better due to specific genes and enzyme activities.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Rosa rugosa extract promotes hair growth and could be a natural treatment for hair loss.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The research found genes and miRNAs that may control hair growth in Forest Musk Deer.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Boosting HGF signaling could improve the creation of hair follicles in lab-made skin.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Keratin 15 is not a reliable sole marker for identifying epidermal stem cells because it's found in various cell types.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.